Mediwelcome Healthcare Management & Technology Inc. AI Stock Analysis
Want to see HK:2159 full AI Analyst Report?
Mediwelcome Healthcare Management & Technology Inc. (2159) AI Stock Analysis
Mediwelcome Healthcare Management & Technology Inc.
(HKEX:2159)
The overall score of 55 reflects a company in the early stages of a financial turnaround, supported by a low valuation. The most significant positive factor is the strong revenue growth and return to profitability, which is partially offset by weak technical momentum and fragile cash flow quality. The low P/E ratio provides a valuation cushion, but the absence of positive technical signals and dividends limits upside conviction.
Mediwelcome Healthcare Management & Technology Inc. (2159) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 524.68M
- Dividend Yield
- ―
- Average Volume (3M)
- 115.98K
- Price to Earnings (P/E)
- 9.8
- Beta (1Y)
- 0.71
- Revenue Growth
- 91.32%
- EPS Growth
- ―
- Country
- Hong Kong
- Employees
- 150
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Mediwelcome Healthcare Management & Technology Inc. Business Overview & Revenue Model
Company Description
As an investment holding entity, Mediwelcome Healthcare Management & Technology Inc. delivers comprehensive marketing solutions for the healthcare sector within the People's Republic of China. Its service portfolio encompasses medical conference orga...
Mediwelcome Healthcare Management & Technology Inc. Financial Statement Overview
Summary
The company shows a strong revenue rebound and a return to profitability, but margins remain thin and historical volatility tempers the outlook. The balance sheet is improving with lower leverage, yet a declining asset base and modest cash generation indicate the turnaround is still fragile.
Income Statement
55NeutralBalance Sheet
50NeutralCash Flow
45Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 568.69M | 468.02M | 321.56M | 331.31M | 323.37M | 708.36M |
| Gross Profit | 141.70M | 94.71M | 51.00M | 29.89M | 32.55M | 93.60M |
| EBITDA | 30.45M | 6.67M | -25.86M | -74.53M | -69.08M | 26.17M |
| Net Income | 33.77M | 9.99M | -45.24M | -94.10M | -89.20M | 4.64M |
Balance Sheet | ||||||
| Total Assets | 447.83M | 190.57M | 194.09M | 214.32M | 317.83M | 366.70M |
| Cash, Cash Equivalents and Short-Term Investments | 138.52M | 99.36M | 71.66M | 80.35M | 154.02M | 174.83M |
| Total Debt | 65.10M | 54.49M | 47.73M | 31.13M | 26.48M | 25.18M |
| Total Liabilities | 267.64M | 85.14M | 120.81M | 94.35M | 116.97M | 73.21M |
| Stockholders Equity | 129.85M | 111.30M | 71.14M | 116.13M | 195.02M | 283.11M |
Cash Flow | ||||||
| Free Cash Flow | 3.73M | 2.47M | -27.10M | -77.18M | -22.75M | -24.73M |
| Operating Cash Flow | 4.03M | 2.88M | -14.05M | -75.58M | -18.46M | 262.00K |
| Investing Cash Flow | -6.36M | -13.28M | -326.00K | 16.46M | -8.36M | -16.77M |
| Financing Cash Flow | 46.43M | 37.34M | 5.68M | 906.00K | 54.00K | 92.84M |
Mediwelcome Healthcare Management & Technology Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2159, the sentiment is Negative. The current price of 1.58 is below the 20-day moving average (MA) of 1.59, below the 50-day MA of 1.64, and below the 200-day MA of 1.62, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 45.73 is Neutral, neither overbought nor oversold. The STOCH value of 68.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2159.
Mediwelcome Healthcare Management & Technology Inc. Peers Comparison
Overall Rating
HK:183077Outperform
HK:215955Neutral
HK:215851Neutral
HK:990651Neutral
HK:388648Neutral
HK:213841Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | HKD 1.86B | 10.26 | 43.78% | 9.96% | -14.68% | -13.60% | |
| 55Neutral | HKD 519.86M | 9.85 | 28.00% | ― | 91.32% | ― | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 51Neutral | HKD 2.41B | 26.56 | 1.88% | 1.95% | 16.87% | ― | |
| 51Neutral | HKD 936.00M | 23.42 | 5.59% | ― | ― | ― | |
| 48Neutral | HKD 1.10B | 77.14 | 0.48% | 1.11% | -3.26% | ― | |
| 41Neutral | HKD 568.90M | -1.37 | -25.36% | ― | -8.94% | -140.82% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:2159 | Mediwelcome Healthcare Management & Technology Inc. | 1.58 | 0.41 | 35.04% | |
| HK:9906 | Honliv Healthcare Management Group Co Ltd | 1.56 | -0.19 | -10.86% | |
| HK:1830 | Perfect Medical Health Management Limited | 1.46 | 0.20 | 15.97% | |
| HK:2138 | EC Healthcare | 0.47 | -0.13 | -22.50% | |
| HK:2158 | Yidu Tech, Inc. | 2.05 | -2.93 | -58.81% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.16 | -0.08 | -34.41% |
Mediwelcome Healthcare Management & Technology Inc. Corporate Events
Mediwelcome Completes HK$84.72 Million Share Placing to Fund Acquisition
Mediwelcome Healthcare Management & Technology Inc. has completed a placing of 56,480,000 new shares to at least six professional and institutional investors at HK$1.50 per share, raising gross proceeds of HK$84.72 million. The net proceeds of approx...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
